ABO Blood Group, Epstein-Barr virus Infection and Prognosis of Patients with Non-metastatic Nasopharyngeal Carcinoma |
Zhang, Ya-Xiong
(Department of Medical Oncology, Sun Yat-sen University Cancer Center)
Kang, Shi-Yang (Department of Medical Oncology, Sun Yat-sen University Cancer Center) Chen, Gang (Department of Medical Oncology, Sun Yat-sen University Cancer Center) Fang, Wen-Feng (Department of Medical Oncology, Sun Yat-sen University Cancer Center) Wu, Xuan (Department of Medical Oncology, Sun Yat-sen University Cancer Center) You, Hua-Jing (Department of Medical Oncology, Sun Yat-sen University Cancer Center) He, Da-Cheng (Department of Medical Oncology, Sun Yat-sen University Cancer Center) Cao, Ya-Lin (Department of Medical Oncology, Sun Yat-sen University Cancer Center) Liang, Wen-Hua (Department of Medical Oncology, Sun Yat-sen University Cancer Center) Zhang, Li (Department of Medical Oncology, Sun Yat-sen University Cancer Center) |
1 | Cai YL, Li J, Lu AY, et al (2013). Prognostic significance of serum anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 27, 119-22 |
2 | Cheng WM, Chan KH, Chen HL, et al (2002). Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum. Int J Cancer, 97, 489-92. DOI |
3 | Chien YC, Chen JY, Liu MY, et al (2001). Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Eng J Med, 345, 1877-82. DOI ScienceOn |
4 | Chua D, Huang J, Zheng B, et al (2001). Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma. Int J Cancer, 94, 73-80. DOI ScienceOn |
5 | Comoli P, De Palma R, Siena S, et al (2004). Adoptive transfer of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boosts LMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma. Ann Oncol, 15, 113-7. DOI ScienceOn |
6 | Fan H, Nicholls J, Chua D, et al (2004). Laboratory markers of tumor burden in nasopharyngeal carcinoma: a comparison of viral load and serologic tests for Epstein-Barr virus. Int J Cancer, 112, 1036-41. DOI |
7 | Fogg M, Murphy JR, Lorch J, Posner M, Wang F (2013). Therapeutic targeting of regulatory T cells enhances tumor-specific CD8+ T cell responses in Epstein-Barr virus associated nasopharyngeal carcinoma. Virology, 441, 107-13. DOI |
8 | Gao S, Worm J, Guldberg P, et al (2004). Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma. Int J Cancer, 109, 230-7. DOI ScienceOn |
9 | Gates MA, Wolpin BM, Cramer DW, Hankinson SE, Tworoger SS (2011). ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer, 128, 482-6. DOI |
10 | Han BL, Xu XY, Zhang CZ, et al (2012). Systematic review on Epstein-Barr Virus (EBV) DNA in diagnosis of nasopharyngeal carcinoma in Asian populations. Asian Pac J Cancer Prev, 13, 2577-81. 과학기술학회마을 DOI ScienceOn |
11 | Hosoi E (2008). Biological and clinical aspects of ABO blood group system. J Med Invest, 55, 174-82. DOI ScienceOn |
12 | He C, Zhuang HG, Zhang WY (1999). The reaction and biological behavior of immune cells is associated with the prognosis of nasopharyngeal carcinoma in UICC stage III. Chinese J Pathol, 28, 115-8. |
13 | Henle G, Henle W (1976). Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer, 17, 1-7. DOI |
14 | Ho HC, Ng MH, Kwan HC, Chau JC (1976). Epstein-Barr virus specific IgA and IgG serum antibodies in nasopharyngeal carcinoma. Br J Cancer, 34, 655-60. DOI ScienceOn |
15 | Huang TR, Zhang SW, Chen WQ, et al (2012). Trends in nasopharyngeal carcinoma mortality in China, 1973-2005. Asian Pac J Cancer Prev, 13, 2495-502. 과학기술학회마을 DOI ScienceOn |
16 | Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB (2010). ABO blood group and cancer. Eur J Cancer, 46, 3345-50. DOI ScienceOn |
17 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
18 | Jia WH, Luo XY, Feng BJ, et al (2010). Traditional Cantonese diet and nasopharyngeal carcinoma risk: a large-scale casecontrol study in Guangdong, China. BMC Cancer, 10, 446. DOI |
19 | Ji X, Zhang W, Xie C, et al (2011). Nasopharyngeal carcinoma risk by histologic type in central China: impact of smoking, alcohol and family history. Int J Cancer, 129, 724-32. DOI |
20 | Joh HK, Cho E, Choueiri TK (2012). ABO blood group and risk of renal cell cancer. Cancer Epidemiol, 36, 528-32. DOI |
21 | Secondino S, Zecca M, Licitra L, et al (2012). T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results. Ann Oncol, 23, 435-41. DOI |
22 | Low WK, Leong JL, Goh YH, Fong KW (2000). Diagnostic value of Ep-stein-Barr viral serology in nasopharyngeal carcinoma. Otolaryngol Head Neck Surg, 123, 505-7. DOI |
23 | Ouyang PY, Su Z, Mao YP, Liu Q, Xie FY (2013). Prognostic value of ABO blood group in southern Chinese patients with established nasopharyngeal carcinoma. Br J Cancer advance online publication, 559. |
24 | Ozelius LJ, Kwiatkowski DJ, Schuback DE, et al (1992). A genetic linkage map of human chromosome 9q. Genomics, 14, 715-20. DOI |
25 | Rickinson AB, Kieff E (2007) Epstein-Barr virus, 5th ed. eds knipe, D.M.and howley, P.M. fields virology. Lippincott Williams & Wilkins, Philadelphia, PA 2655-700. |
26 | Sam CK, Prasad U, Pathmanathan R (1989). Serological markers in the diagnosis of histopathological types of nasopharyngeal carcinoma. Eur J Surg Oncol, 15, 357-60. |
27 | Sheng L, Sun X, Zhang L, Su D (2013). ABO blood group and nasopharyngeal carcinoma risk in a population of Southeast China. Int J Cancer, 133, 893-7. DOI |
28 | Straathof KC, Bollard CM, Rooney CM, Heslop HE (2003). Immunotherapy for Epstein-Barr virus-associated cancers in children. Oncologist, 8, 83-98. DOI |
29 | Tiwawech D, Srivatanakul P, Karaluk A, Ishida T (2003). Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 4, 113-8. |
30 | Thompson MP, Kurzrock R (2004). Epstein-Barr virus and cancer. Clin Cancer Res, 10, 803-21. DOI ScienceOn |
31 | Wang Z, Liu L, Ji J, et al (2012). ABO Blood Group System and Gastric Cancer: A Case-Control Study and Meta-Analysis. In. J Mo. Sci, 13, 13308-21. DOI |
32 | Wolpin BM, Chan AT, Hartge P, et al (2009). ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst, 101, 424-31. DOI ScienceOn |
33 | Zhang BL, He N, Huang YB et al (2014). ABO blood groups and risk of cancer: a systematic review and meta-analysis. Asian Pac J Cancer Prev, 15, 4643-50. 과학기술학회마을 DOI |
34 | Straathof KC, Bollard CM, Popat U, et al (2005). Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes. Blood, 105, 1898-904. DOI |
35 | Hashim NAN, Ramzi NH, Velapasamy S, et al (2012). Identification of genetic and non-genetic risk factors for nasopharyngeal carcinoma in a southeast Asian population. Asian Pac J Cancer Prev, 13, 6005-10. 과학기술학회마을 DOI ScienceOn |
![]() |